3 hot shares to buy after today’s gains?

An unexpected share price movement could signal time to buy.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One of the first things I do each morning is look to see which shares have risen and fallen the most when the markets opened. I know, it’s sad, but it can throw up unexpected possibilities for further research. Here’s a look at three of today’s winners.

Soaring pharmaceutical

Indivior (LSE: INDV) shares are up 15% to 345p after the company announced a positive result from phase 3 clinical trials of its RBP-6000 buprenorphine drug candidate for treating people addicted to opioids. The drug, which the firm described as possibly life-transforming, should hopefully now get the nod from the US Food and Drug Administration for further trials — and Indivior suggests it could be on the market as early as Q4 2017.

With the shares at record highs, have investors missed the boat? I don’t think so. We’re still only looking at a P/E multiple of 16. And while that’s a little above the FTSE 100‘s long-term average, I think it’s low for a pharmaceuticals researcher with such a promising prospect in its hands — and Indivior is nicely profitable, unlike some smaller researchers who are burning cash.

Misuse of drugs like heroin, morphine and prescription painkillers is being increasingly seen as a problem that needs to be addressed, and if this stuff fulfils its early hopes it could end up making Indivior shares look super-cheap today.

Profit from housing?

If housebuilders are in the dumps, that shouldn’t affect estate agents and property service companies, should it? That’s what investors in Savills (LSE: SVS) are presumably thinking, as the shares have put on 7% today to 748p. Savills shares were hit hard by Brexit fallout, but with today’s rise they’ve recovered a good bit of the loss and are now only 4% down since the day.

The latest boost came from an upgrade by Citigroup, from neutral to buy, based on Savills’ recent upbeat first-half figures. I agree. Savills only gets about 10% of its annual turnover from the EU, so there seems to be little Brexit danger, and with the shares having slipped over the past year they’re now valued at under 12 times forecast earnings, with dividend yields approaching 4%.

Net debt is low and Savills’ full-year expectations remain unchanged, so those forecasts should be close to the mark. The shares look cheap to me.

Strength in defence

The aerospace and defence sector has faced a few years of pressure, and that’s helped push Cobham (LSE: COB) shares down 43% since February 2015, including a big drop in April after the firm issued a profit warning. But today’s news of the arrival of a new chief executive in the shape of Laird boss David Lockwood, to replace the incumbent Bob Murphy, has cheered investors — and the share price is up 3.5% to 166p.

I’ve always been fairly bullish about the long-term prospects for the sector, though I think Cobham has needed a bit of a kick in the pants to shake it up for a while. This new appointment could be what the doctor ordered, and I wouldn’t be surprised to see a few radical changes when Mr Lockwood takes the helm — such transitions are often a trigger for a clean review of a business and the shedding of unnecessary costs.

We could see more hardship and perhaps a bit of belt-tightening before growth returns, but I’m cautiously optimistic.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »